Intended for healthcare professionals


Novartis found to be in breach of code over drug brochure

BMJ 2013; 346 doi: (Published 21 June 2013) Cite this as: BMJ 2013;346:f4061
  1. Jacqui Wise
  1. 1London

Novartis has been found to have made several breaches of the drug advertising code of practice over a brochure promoting a new drug for chronic obstructive pulmonary disease (COPD).1

The Drug and Therapeutics Bulletin made several specific complaints about the evidence used and the claims made in …

View Full Text

Log in

Log in through your institution


* For online subscription